Dermatomyositis Does Not Typically Cause Elevated Hematocrit
Dermatomyositis is not associated with elevated hematocrit; in fact, anemia (low hematocrit) is a common laboratory finding in this condition. If you encounter elevated hematocrit in a patient with dermatomyositis, you should investigate alternative causes rather than attributing it to the myositis itself.
Expected Hematologic Abnormalities in Dermatomyositis
Based on comprehensive laboratory analysis of 620 PM/DM patients, low hematocrit levels occurred in 29% of patients, making anemia a frequent finding 1. The typical hematologic abnormalities you should expect include:
- Low hematocrit (29% of patients) - anemia is common
- Elevated white blood cell counts (36%)
- Low lymphocyte counts (37%)
- Elevated erythrocyte sedimentation rate (33%)
Standard Laboratory Workup
When evaluating dermatomyositis, the recommended initial laboratory assessment includes a complete blood count (which measures hematocrit), along with liver function tests, inflammatory markers, and muscle enzymes 2. The characteristic laboratory elevations in dermatomyositis are:
- Muscle enzymes: Creatine kinase (51%), aldolase (65%), AST (51%), ALT (43%), LDH (60%), myoglobin (48%)
- Inflammatory markers: ESR and CRP elevations
- Immunoglobulins: Elevated IgM (16%) and IgG (18%)
Clinical Pitfall to Avoid
If you find elevated hematocrit in a dermatomyositis patient, do not dismiss it as disease-related. This finding warrants investigation for:
- Secondary polycythemia (chronic hypoxia from interstitial lung disease, though this would be unusual)
- Dehydration
- Concurrent hematologic disorders
- Underlying malignancy (remember that 20% of adult DM patients have associated cancer 3, and certain malignancies can cause polycythemia)
The presence of elevated hematocrit should prompt enhanced cancer screening, particularly given that dermatomyositis carries significant malignancy risk, with the highest risk in the three years surrounding diagnosis 4.
Why This Matters for Patient Outcomes
Recognizing that anemia—not polycythemia—is the expected hematologic abnormality prevents you from missing important alternative diagnoses. The anemia in dermatomyositis likely reflects chronic inflammation, and its presence correlates with other disease markers 1. Misattributing an elevated hematocrit to dermatomyositis could delay diagnosis of a treatable underlying condition or associated malignancy, directly impacting morbidity and mortality.